HR - Healthcare Realty Trust Incorporated
Healthcare Realty Trust (HR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Healthcare Realty Trust NYSE: HR reported second-quarter results marked by higher occupancy, leasing activity, same-store net operating income growth and an increase to its full-year funds-from-operations outlook. Management said the company's performance continues to run ahead of objectives outlined in its strategic plan one year ago.
Healthcare Realty Trust Incorporated (HR) Q2 2026 Earnings Call Transcript
Healthcare Realty Trust (HR) came out with quarterly funds from operations (FFO) of $0.41 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to FFO of $0.41 per share a year ago.
NASHVILLE, Tenn., July 30, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the second quarter ended June 30, 2026. In addition, the Company announced an increased 2026 Normalized FFO guidance range of $1.62 to $1.66 per share (diluted), a $0.02 increase at the midpoint from April guidance, and an increased Same Store Cash NOI growth guidance range of 4.25% to 5.00% (+50bps increase at the low end and +25bps at the high end from April guidance).
NASHVILLE, Tenn., July 07, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced that on Thursday, July 30, 2026, after the market closes, it is scheduled to report results for the second quarter of 2026.
enGene Therapeutics Inc. (Nasdaq: ENGN, âenGeneâ or the âCompanyâ), a clinical-stage, non-viral genetic medicines company today announced its financial
EXPD, VNCE, UCTT, PRG and TNET have been added to the Zacks Rank #1 (Strong Buy) List on June 8, 2026.
Further positive results from the Phase III SERENA-6 trial showed AstraZeneca's camizestrant plus a cyclin-dependent kinase (CDK) 4/6 inhibitor â palbociclib
Summit Therapeutics Inc. (NASDAQ: SMMT) today announced positive overall survival (OS) results from the Phase III HARMONi-6 trial, conducted in China and spons
[url="]Exelixis, Inc.[/url] (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYXÂ
Healthcare Realty Trust is well positioned in the outpatient medical REIT space, benefiting from macro trends like aging demographics and rising outpatient care demand. HR's growth is supported by a nationwide portfolio, strong tenant retention, and opportunities for property acquisitions and lease growth. Balance sheet risk is mitigated by competitive debt metrics and diversified asset exposure.
AstraZeneca and Daiichi Sankyo's ENHERTUÂ (fam-trastuzumab deruxtecan-nxki) has been approved by the US Food and Drug Administration (FDA) for both the neoadj
H&R Real Estate Investment Trust (HR.UN:CA) Q1 2026 Earnings Call Transcript
D2L Survey Reveals How AI is Beginning to Reshape Entry-Level Work and the Talent Pipeline PR Newswire TORONTO,
NASHVILLE, Tenn., May 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE: HR) (“Healthcare Realty”) today announced that its operating partnership, Healthcare Realty Holdings, L.P. (“Healthcare Realty L.P.”), priced its offering of $600,000,000 aggregate principal amount of 3.00% exchangeable senior notes due 2032 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering size of $500,000,000 aggregate principal amount of notes. Healthcare Realty will fully and unconditionally guarantee the notes on a senior, unsecured basis. The issuance and sale of the notes are scheduled to settle on May 7, 2026, subject to customary closing conditions. Healthcare Realty L.P. also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $100,000,000 aggregate principal amount of notes.
NASHVILLE, Tenn., May 04, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE: HR) (“Healthcare Realty”) today announced that its operating partnership, Healthcare Realty Holdings, L.P.
U.S. equity markets advanced for a fifth straight week - their longest winning streak since 2024 - as strong earnings, resilient data, and hopes for lasting Iran peace fueled optimism. Investors looked through another oil-price surge and inflationary pressure, focusing instead on corporate resilience and economic strength despite a complex macro backdrop shaped by geopolitical and policy uncertainty. The Fed held rates steady in an unusually fractured 8-4 vote, while Powell's plan to remain on the Board broke precedent and raised politically charged succession questions.
Healthcare Realty Trust Incorporated (HR) Q1 2026 Earnings Call Transcript
NASHVILLE, Tenn., April 30, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the first quarter ended March 31, 2026.